Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SCHOOL SPECIALTY INCSCOO · Entity 16699 | Director · 10% owner | September 24, 2019 | October 02, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SCHOOL SPECIALTY INC
Report date September 24, 2019 · Filed October 02, 2019
Jointly reported with Mill Road Capital II, L.P., Mill Road Capital II GP LLC, LYNCH THOMAS E, Jacobs Justin
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par valueSEC Table I · non-derivative | IndirectSee footnote | 3,870 |
Reported balance
After 2019-09-24 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2019-09-24 · Other · Acquired 3,870 · Balance 3,870 F1: Represents restricted stock units ("RSUs") granted by the issuer to Mr. Yanagi in accordance with Rule 16b-3(d) (as described in transaction code "A") as compensation for serving as a member of the issuer's board of directors, in which the Reporting Persons may have an indirect pecuniary interest. Pursuant to a pre-existing contractual obligation, Mill Road Capital Management, LLC (the "Management Company"), an affiliate of the Reporting Persons that does not have Section 13(d) beneficial ownership of any securities of the issuer, has the right to receive the economic benefit of the reported shares and, accordingly, Mr. Yanagi has no direct pecuniary interest in such shares. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. |
| Common Stock, $0.001 par valueSEC Table I · non-derivative | IndirectSee footnote | 6,865 |
Reported balance
Holding disclosure · report date 2019-09-24 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 6,865 F3: Represents RSUs (or shares issued upon the vesting thereof) granted by the issuer as director compensation, in which the Reporting Persons may have an indirect pecuniary interest. The Management Company has the right to receive the economic benefit of the reported shares pursuant to a contractual obligation with the holder of such shares. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. |
| Common Stock, $0.001 par valueSEC Table I · non-derivative | IndirectSee footnote | 3,870 |
Reported balance
Holding disclosure · report date 2019-09-24 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 3,870 F3: Represents RSUs (or shares issued upon the vesting thereof) granted by the issuer as director compensation, in which the Reporting Persons may have an indirect pecuniary interest. The Management Company has the right to receive the economic benefit of the reported shares pursuant to a contractual obligation with the holder of such shares. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. |
| Common Stock, $0.001 par valueSEC Table I · non-derivative | Direct | 2,423,516 |
Reported balance
Holding disclosure · report date 2019-09-24 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,423,516 F2: The shares reported are directly held by Mill Road Capital II, L.P. (the "Fund"). Mill Road Capital II GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") granted by the issuer to Mr. Yanagi in accordance with Rule 16b-3(d) (as described in transaction code "A") as compensation for serving as a member of the issuer's board of directors, in which the Reporting Persons may have an indirect pecuniary interest. Pursuant to a pre-existing contractual obligation, Mill Road Capital Management, LLC (the "Management Company"), an affiliate of the Reporting Persons that does not have Section 13(d) beneficial ownership of any securities of the issuer, has the right to receive the economic benefit of the reported shares and, accordingly, Mr. Yanagi has no direct pecuniary interest in such shares. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
F2: The shares reported are directly held by Mill Road Capital II, L.P. (the "Fund"). Mill Road Capital II GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
F3: Represents RSUs (or shares issued upon the vesting thereof) granted by the issuer as director compensation, in which the Reporting Persons may have an indirect pecuniary interest. The Management Company has the right to receive the economic benefit of the reported shares pursuant to a contractual obligation with the holder of such shares. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Performant Healthcare Inc
Report date October 21, 2025 · Filed October 22, 2025
Section 16 reporting ended · disclosed 2025-10-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.0001 par valueSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2025-10-21 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-10-21 · Disposition to issuer · Disposed 3,261,675 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated July 31, 2025 (the "Merger Agreement"), by and among Performant Healthcare, Inc. ("Performant" or "Company"), Continental Buyer, Inc., a Delaware corporation ("Continental" or "Parent") and Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Continental ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Performant, with Performant surviving the merger as a wholly-owned subsidiary of Continental (the "Merger"). F2: Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement. F3: The shares reported are directly held by Mill Road Capital II, L.P. (the "Fund"). Mr. Yanagi is a management committee director of Mill Road Capital II GP LLC, which is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. |
| Common Stock, $0.0001 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-10-21 transaction · row 2
1 source rowRow 2 · 2025-10-21 · Other · Disposed 381,835 · Balance 0 F4: Represents the cancelation (as described in footnote 5 below) of the Reporting Person's indirect pecuniary interest in restricted stock units ("RSUs") granted by the Company to Mr. Yanagi in accordance with Rule 16b-3(d) (as described in transaction code "A") as compensation for serving as a member of the Company's board of directors. Each RSU represented the right to receive one share of Common Stock. Pursuant to a pre-existing contractual obligation, Mill Road Capital Management, LLC, an affiliate of the Reporting Person that does not have Section 13(d) beneficial ownership of any securities of the Company, had the right to receive the economic benefit of the reported shares and, accordingly, Mr. Yanagi had no direct pecuniary interest in such shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. F5: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated July 31, 2025 (the "Merger Agreement"), by and among Performant Healthcare, Inc. ("Performant" or "Company"), Continental Buyer, Inc., a Delaware corporation ("Continental" or "Parent") and Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Continental ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Performant, with Performant surviving the merger as a wholly-owned subsidiary of Continental (the "Merger").
F2: Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement.
F3: The shares reported are directly held by Mill Road Capital II, L.P. (the "Fund"). Mr. Yanagi is a management committee director of Mill Road Capital II GP LLC, which is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any.
F4: Represents the cancelation (as described in footnote 5 below) of the Reporting Person's indirect pecuniary interest in restricted stock units ("RSUs") granted by the Company to Mr. Yanagi in accordance with Rule 16b-3(d) (as described in transaction code "A") as compensation for serving as a member of the Company's board of directors. Each RSU represented the right to receive one share of Common Stock. Pursuant to a pre-existing contractual obligation, Mill Road Capital Management, LLC, an affiliate of the Reporting Person that does not have Section 13(d) beneficial ownership of any securities of the Company, had the right to receive the economic benefit of the reported shares and, accordingly, Mr. Yanagi had no direct pecuniary interest in such shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any.
F5: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 21, 2025 Filed Oct 22, 2025 13:24 UTC | Performant Healthcare Inc PHLT · Entity 74046 | OtherCommon Stock, $0.0001 par value | 381,835 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-246336 · ownership.xml · nonDerivative · entry 2 Yanagi Eric · CIK 0001789758 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F4 · kind: Represents the cancelation (as described in footnote 5 below) of the Reporting Person's indirect pecuniary interest in restricted stock units ("RSUs") granted by the Company to Mr. Yanagi in accordance with Rule 16b-3(d) (as described in transaction code "A") as compensation for serving as a member of the Company's board of directors. Each RSU represented the right to receive one share of Common Stock. Pursuant to a pre-existing contractual obligation, Mill Road Capital Management, LLC, an affiliate of the Reporting Person that does not have Section 13(d) beneficial ownership of any securities of the Company, had the right to receive the economic benefit of the reported shares and, accordingly, Mr. Yanagi had no direct pecuniary interest in such shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. F5 · kind: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration. F5 · price: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration. Read SEC document |
| October 21, 2025 Filed Oct 22, 2025 13:24 UTC | Performant Healthcare Inc PHLT · Entity 74046 | Disposition to issuerCommon Stock, $0.0001 par value | 3,261,675 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-246336 · ownership.xml · nonDerivative · entry 1 Yanagi Eric · CIK 0001789758 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger, dated July 31, 2025 (the "Merger Agreement"), by and among Performant Healthcare, Inc. ("Performant" or "Company"), Continental Buyer, Inc., a Delaware corporation ("Continental" or "Parent") and Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Continental ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Performant, with Performant surviving the merger as a wholly-owned subsidiary of Continental (the "Merger"). F2 · kind: Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement. F2 · price: Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement. F3 · ownership.direct: The shares reported are directly held by Mill Road Capital II, L.P. (the "Fund"). Mr. Yanagi is a management committee director of Mill Road Capital II GP LLC, which is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| July 28, 2025 Filed Jul 28, 2025 19:00 UTC | Performant Healthcare Inc PFMT · Entity 74046 | OtherCommon Stock, $0.0001 par value | 35,616 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-099307 · ownership.xml · nonDerivative · entry 1 Yanagi Eric · CIK 0001789758 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,835 F1 · kind: Represents the Reporting Person's acquisition of an indirect pecuniary interest in restricted stock units ("RSUs") granted by the issuer to Mr. Yanagi in accordance with Rule 16b-3(d) (as described in transaction code "A") as compensation for serving as a member of the issuer's board of directors. Each RSU represents the right to receive one share of the issuer's common stock, and the RSUs will vest on the earlier of the issuer's 2026 annual meeting of stockholders or a change of control. Pursuant to a pre-existing contractual obligation, Mill Road Capital Management, LLC, an affiliate of the Reporting Person that does not have Section 13(d) beneficial ownership of any securities of the issuer, has the right to receive the economic benefit of the reported shares and, accordingly, Mr. Yanagi has no direct pecuniary interest in such shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 17:19 UTC | Performant Healthcare Inc PFMT · Entity 74046 | OtherCommon Stock, $0.0001 par value | 36,011 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-089444 · ownership.xml · nonDerivative · entry 1 Yanagi Eric · CIK 0001789758 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,219 F1 · kind: Represents the Reporting Person's acquisition of an indirect pecuniary interest in restricted stock units ("RSUs") granted by the issuer to Mr. Yanagi in accordance with Rule 16b-3(d) (as described in transaction code "A") as compensation for serving as a member of the issuer's board of directors. Each RSU represents the right to receive one share of the issuer's common stock, and the RSUs will vest on the earlier of the issuer's 2025 annual meeting of stockholders or a change of control. Pursuant to a pre-existing contractual obligation, Mill Road Capital Management, LLC, an affiliate of the Reporting Person that does not have Section 13(d) beneficial ownership of any securities of the issuer, has the right to receive the economic benefit of the reported shares and, accordingly, Mr. Yanagi has no direct pecuniary interest in such shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 16:35 UTC | Performant Healthcare Inc PFMT · Entity 74046 | OtherCommon Stock, $0.0001 par value | 27,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002059 · doc4.xml · nonDerivative · entry 2 Yanagi Eric · CIK 0001789758 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,208 F2 · kind: Represents the Reporting Person's acquisition of an indirect pecuniary interest in restricted stock units ("RSUs") granted by the issuer to Mr. Yanagi in accordance with Rule 16b-3(d) (as described in transaction code "A") as compensation for serving as a member of the issuer's board of directors. Each RSU represents the right to receive one share of the issuer's common stock, and the RSUs will vest on the earlier of the issuer's 2024 annual meeting of stockholders or a change of control. Pursuant to a pre-existing contractual obligation, Mill Road Capital Management, LLC, an affiliate of the Reporting Person that does not have Section 13(d) beneficial ownership of any securities of the issuer, has the right to receive the economic benefit of the reported shares and, accordingly, Mr. Yanagi has no direct pecuniary interest in such shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| August 26, 2022 Filed Aug 30, 2022 19:14 UTC | Performant Healthcare Inc PFMT · Entity 74046 | OtherCommon Stock, $0.0001 par value | 35,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-048065 · doc4.xml · nonDerivative · entry 2 Yanagi Eric · CIK 0001789758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,533 F2 · kind: Represents the Reporting Person's acquisition of an indirect pecuniary interest in restricted stock units ("RSUs") granted by the issuer to Mr. Yanagi in accordance with Rule 16b-3(d) (as described in transaction code "A") as compensation for serving as a member of the issuer's board of directors. Each RSU represents the right to receive one share of the issuer's common stock, and the RSUs will vest on the earlier of the issuer's 2023 annual meeting of stockholders or a change of control. Pursuant to a pre-existing contractual obligation, Mill Road Capital Management, LLC, an affiliate of the Reporting Person that does not have Section 13(d) beneficial ownership of any securities of the issuer, has the right to receive the economic benefit of the reported shares and, accordingly, Mr. Yanagi has no direct pecuniary interest in such shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 16:52 UTC | Performant Healthcare Inc PFMT · Entity 74046 | OtherCommon Stock, $0.0001 par value | 16,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054795 · doc4.xml · nonDerivative · entry 2 Yanagi Eric · CIK 0001789758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,156 F2 · kind: Represents the Reporting Person's acquisition of an indirect pecuniary interest in restricted stock units ("RSUs") granted by the issuer to Mr. Yanagi in accordance with Rule 16b-3(d) (as described in transaction code "A") as compensation for serving as a member of the issuer's board of directors. Each RSU represents the right to receive one share of the issuer's common stock, and the RSUs will vest on the earlier of the issuer's 2022 annual meeting of stockholders or a change of control. Pursuant to a pre-existing contractual obligation, Mill Road Capital Management, LLC, an affiliate of the Reporting Person that does not have Section 13(d) beneficial ownership of any securities of the issuer, has the right to receive the economic benefit of the reported shares and, accordingly, Mr. Yanagi has no direct pecuniary interest in such shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 08, 2021 Filed Jun 8, 2021 20:28 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, $0.0001 par value | 5,503 | $5.05 | $27,790.15 |
DisclosureSEC source: 0001209191-21-039062 · doc4.xml · nonDerivative · entry 4 Yanagi Eric · CIK 0001789758 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,261,675 F3 · ownership.direct: The shares reported are directly held by Mill Road Capital II, L.P. (the "Fund"). Mr. Yanagi is a management committee director of Mill Road Capital II GP LLC (the "GP"), which is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 20:28 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, $0.0001 par value | 208,800 | $4.83 | $1,008,504.00 |
DisclosureSEC source: 0001209191-21-039062 · doc4.xml · nonDerivative · entry 3 Yanagi Eric · CIK 0001789758 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,267,178 F4 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $4.83 and $4.95. Full information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the issuer, or a security holder of the issuer. F3 · ownership.direct: The shares reported are directly held by Mill Road Capital II, L.P. (the "Fund"). Mr. Yanagi is a management committee director of Mill Road Capital II GP LLC (the "GP"), which is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:28 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, $0.0001 par value | 3,637 | $5.05 | $18,366.85 |
DisclosureSEC source: 0001209191-21-039062 · doc4.xml · nonDerivative · entry 2 Yanagi Eric · CIK 0001789758 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,475,978 F2 · price: This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $4.95 and $5.05. Full information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the issuer, or a security holder of the issuer. F3 · ownership.direct: The shares reported are directly held by Mill Road Capital II, L.P. (the "Fund"). Mr. Yanagi is a management committee director of Mill Road Capital II GP LLC (the "GP"), which is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 05, 2020 Filed May 7, 2020 16:09 UTC | Performant Healthcare Inc PFMT · Entity 74046 | OtherCommon Stock, $0.0001 par value | 98,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027650 · doc4.xml · nonDerivative · entry 2 Yanagi Eric · CIK 0001789758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,415 F2 · kind: Represents the Reporting Person's acquisition of an indirect pecuniary interest in restricted stock units ("RSUs") granted by the issuer to Mr. Yanagi in accordance with Rule 16b-3(d) (as described in transaction code "A") as compensation for serving as a member of the issuer's board of directors. Each RSU represents the right to receive one share of the issuer's common stock, and the RSUs will vest on the earlier of the issuer's 2021 annual meeting of stockholders or a change of control. Pursuant to a pre-existing contractual obligation, Mill Road Capital Management, LLC, an affiliate of the Reporting Persons that does not have Section 13(d) beneficial ownership of any securities of the issuer, has the right to receive the economic benefit of the reported shares and, accordingly, Mr. Yanagi has no direct pecuniary interest in such shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 05, 2020 Filed May 7, 2020 16:09 UTC | Performant Healthcare Inc PFMT · Entity 74046 | OtherCommon Stock, $0.0001 par value | 131,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027650 · doc4.xml · nonDerivative · entry 1 Yanagi Eric · CIK 0001789758 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,666 F1 · kind: Represents the Reporting Person's acquisition of an indirect pecuniary interest in restricted stock units ("RSUs") granted by the issuer to Mr. Yanagi in accordance with Rule 16b-3(d) (as described in transaction code "A") as compensation for serving as a member of the issuer's board of directors. Each RSU represents the right to receive one share of the issuer's common stock, and the RSUs will vest in four equal annual installments over a four year period, or upon a change of control. Pursuant to a pre-existing contractual obligation, Mill Road Capital Management, LLC, an affiliate of the Reporting Persons that does not have Section 13(d) beneficial ownership of any securities of the issuer, has the right to receive the economic benefit of the reported shares and, accordingly, Mr. Yanagi has no direct pecuniary interest in such shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. Read SEC document |
| September 24, 2019 Filed Oct 2, 2019 16:24 UTC | SCHOOL SPECIALTY INC SCOO · Entity 16699 | OtherCommon Stock, $0.001 par value | 3,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051682 · doc4.xml · nonDerivative · entry 1 Mill Road Capital II, L.P. · CIK 0001550729 · 10% owner Yanagi Eric · CIK 0001789758 · Director · 10% owner Mill Road Capital II GP LLC · CIK 0001550728 · 10% owner LYNCH THOMAS E · CIK 0001244666 · 10% owner Jacobs Justin · CIK 0001464667 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,870 F1 · kind: Represents restricted stock units ("RSUs") granted by the issuer to Mr. Yanagi in accordance with Rule 16b-3(d) (as described in transaction code "A") as compensation for serving as a member of the issuer's board of directors, in which the Reporting Persons may have an indirect pecuniary interest. Pursuant to a pre-existing contractual obligation, Mill Road Capital Management, LLC (the "Management Company"), an affiliate of the Reporting Persons that does not have Section 13(d) beneficial ownership of any securities of the issuer, has the right to receive the economic benefit of the reported shares and, accordingly, Mr. Yanagi has no direct pecuniary interest in such shares. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. F1 · ownership.nature: Represents restricted stock units ("RSUs") granted by the issuer to Mr. Yanagi in accordance with Rule 16b-3(d) (as described in transaction code "A") as compensation for serving as a member of the issuer's board of directors, in which the Reporting Persons may have an indirect pecuniary interest. Pursuant to a pre-existing contractual obligation, Mill Road Capital Management, LLC (the "Management Company"), an affiliate of the Reporting Persons that does not have Section 13(d) beneficial ownership of any securities of the issuer, has the right to receive the economic benefit of the reported shares and, accordingly, Mr. Yanagi has no direct pecuniary interest in such shares. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.